---
figid: PMC4422811__kcam-09-125-g002
figlink: /pmc/articles/PMC4422811/figure/f0002/
number: Figure 2
caption: Schematic representation of survival signaling vs. proliferative signaling
  from the EGF receptor based on surface restriction of EGFR activation. The TNC EGF-like
  repeats provide for less efficient activation of the Ras-Raf-ERK and PI3kinase-Akt
  pathways in a persistent staccato manner; this leads to survival signaling. However,
  soluble EGF ligands drive EGFR internalization with the endosomal active EGFR efficiently
  signaling via the Ras-Raf-ERK pathway to drive mitogenesis. Not shown are the motogenic
  pathways (PLCgamma, ERK-calpain II, and PKCdelta) that are preferentially signaled
  from surface restricted EGFR.
pmcid: PMC4422811
papertitle: Tenascin-C Signaling in melanoma.
reftext: Hanshuang Shao, et al. Cell Adh Migr. 2015 Jan-Apr;9(1-2):125-130.
pmc_ranked_result_index: '34776'
pathway_score: 0.9412368
filename: kcam-09-125-g002.jpg
figtitle: Survival signaling vs
year: '2015'
organisms: Homo sapiens
ndex: 0f1bb021-df03-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4422811__kcam-09-125-g002.html
  '@type': Dataset
  description: Schematic representation of survival signaling vs. proliferative signaling
    from the EGF receptor based on surface restriction of EGFR activation. The TNC
    EGF-like repeats provide for less efficient activation of the Ras-Raf-ERK and
    PI3kinase-Akt pathways in a persistent staccato manner; this leads to survival
    signaling. However, soluble EGF ligands drive EGFR internalization with the endosomal
    active EGFR efficiently signaling via the Ras-Raf-ERK pathway to drive mitogenesis.
    Not shown are the motogenic pathways (PLCgamma, ERK-calpain II, and PKCdelta)
    that are preferentially signaled from surface restricted EGFR.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK1
  - AKT1
  - NFKB1
  - ARAF
  - AKT3
  - KRAS
  - XIAP
  - NRAS
  - EGFR
  - FOXO1
  - HRAS
  - BCL2L11
  - MAPK3
  - PGF
  - MAP2K1
  - BCL2
  - VEGFD
  - MAP2K2
  - BRAF
  - FOXO4
  - RAF1
  - BAD
  - BCL2L1
  - AKT2
  - VEGFC
  - FOXO3
  - EGF
  - VEGFB
  - VEGFA
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: AKT/PKB
  symbol: PKB
  source: hgnc_alias_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: NF-kB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: AKT/PKB
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: XIAP
  symbol: XIAP
  source: hgnc_symbol
  hgnc_symbol: XIAP
  entrez: '331'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: Foxo1
  symbol: FOXO1
  source: hgnc_symbol
  hgnc_symbol: FOXO1
  entrez: '2308'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: Bim
  symbol: BIM
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2L11
  entrez: '10018'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: MEK1/2
  symbol: MEK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: Bcl2
  symbol: BCL2
  source: hgnc_symbol
  hgnc_symbol: BCL2
  entrez: '596'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: MEK1/2
  symbol: MEK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: Foxo4
  symbol: FOXO4
  source: hgnc_symbol
  hgnc_symbol: FOXO4
  entrez: '4303'
- word: AKT/PKB
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: Bad
  symbol: BAD
  source: hgnc_symbol
  hgnc_symbol: BAD
  entrez: '572'
- word: Bcl-xl
  symbol: bcl-xL
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2L1
  entrez: '598'
- word: AKT/PKB
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: Foxo3
  symbol: FOXO3
  source: hgnc_symbol
  hgnc_symbol: FOXO3
  entrez: '2309'
- word: EGF
  symbol: EGF
  source: hgnc_symbol
  hgnc_symbol: EGF
  entrez: '1950'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
